JP2012233113A - Curing composition, and optical adhesive - Google Patents

Curing composition, and optical adhesive Download PDF

Info

Publication number
JP2012233113A
JP2012233113A JP2011103642A JP2011103642A JP2012233113A JP 2012233113 A JP2012233113 A JP 2012233113A JP 2011103642 A JP2011103642 A JP 2011103642A JP 2011103642 A JP2011103642 A JP 2011103642A JP 2012233113 A JP2012233113 A JP 2012233113A
Authority
JP
Japan
Prior art keywords
component
meth
curable composition
acrylate
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011103642A
Other languages
Japanese (ja)
Other versions
JP5754233B2 (en
Inventor
Hitoshi Okazaki
仁 岡崎
Kosuke Namiki
康佑 並木
Motoharu Takeuchi
基晴 竹内
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Gas Chemical Co Inc
Original Assignee
Mitsubishi Gas Chemical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Gas Chemical Co Inc filed Critical Mitsubishi Gas Chemical Co Inc
Priority to JP2011103642A priority Critical patent/JP5754233B2/en
Priority to CN201280020113.7A priority patent/CN103562271B/en
Priority to PCT/JP2012/060903 priority patent/WO2012147712A1/en
Priority to TW101114703A priority patent/TWI529488B/en
Publication of JP2012233113A publication Critical patent/JP2012233113A/en
Application granted granted Critical
Publication of JP5754233B2 publication Critical patent/JP5754233B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polymerisation Methods In General (AREA)
  • Adhesives Or Adhesive Processes (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a curing composition having a further higher refractive index and having the performances as an optical adhesive such as low shrinkage, photocurability, transparency and colorlessness, and the viscosity suitable for working.SOLUTION: The curing composition contains a poly(meth)acrylate compound (A component) having a fluorene ring, a polythiol compound (B component) represented by a specific formula, and a photopolymerization initiator (C component).

Description

本発明は、複合光学素子を作製する際に使用される光学用接着剤に関するものである。 The present invention relates to an optical adhesive used for producing a composite optical element.

アクリレート化合物等を主成分とする光硬化性組成物は、光学素子を作製する際の接着剤として幅広く使用されている。接着剤にとって、接着性、硬化性、機械的強度、耐久性、および光学特性は基本性能であるが、近年では光学素子の高機能化に伴って、屈折率が重要な性能になっている。特に接着剤の高屈折率化は光学設計の自由度が広がるので要望が高い。高い屈折率を有する接着剤が使用される用途例としては、2枚のレンズの張り合わせで構成される色消しレンズ(アクロマートレンズ)、ガラスと樹脂の複合で構成されるハイブリッド型非球面レンズ、ダイクロイックプリズムなどの複雑形状をしたプリズム等が挙げられる。これらの用途に使用される接着剤には、高い屈折率だけでなく、密着性、光硬化性、無色透明性、作業に適した粘度といった性能も当然要求される。 A photocurable composition mainly composed of an acrylate compound or the like is widely used as an adhesive for producing an optical element. For adhesives, adhesiveness, curability, mechanical strength, durability, and optical properties are basic performances, but in recent years, the refractive index has become an important performance as the functionality of optical elements increases. In particular, increasing the refractive index of the adhesive is highly desired because the degree of freedom in optical design is expanded. Examples of applications in which an adhesive having a high refractive index is used include an achromatic lens (achromatic lens) composed of two lenses bonded together, a hybrid aspherical lens composed of a composite of glass and resin, and dichroic Examples include prisms having complicated shapes such as prisms. Adhesives used for these applications naturally require not only a high refractive index but also performance such as adhesion, photocurability, colorless transparency, and viscosity suitable for work.

高い屈折率を有する多官能(メタ)アクリレート化合物としては、9,9−ビス(4−(2−アクリロキシエトキシ)フェニル)フルオレン(以下、A−BPEFと呼ぶ)(硬化物の屈折率1.62)や4,4’−ビス(メタクリロイルチオ)ジフェニルスルフィド(以下、MPSMAと呼ぶ)(硬化物の屈折率1.69)等が知られている。しかしながら、これらの化合物は常温で固体であるため、単独での使用は難しい。 As a polyfunctional (meth) acrylate compound having a high refractive index, 9,9-bis (4- (2-acryloxyethoxy) phenyl) fluorene (hereinafter referred to as A-BPEF) (refractive index of cured product 1. 62), 4,4′-bis (methacryloylthio) diphenyl sulfide (hereinafter referred to as MPSMA) (refractive index of cured product 1.69) and the like are known. However, since these compounds are solid at room temperature, it is difficult to use them alone.

また、一般的に多官能(メタ)アクリレート化合物は硬化に伴う収縮が大きく、接着剤として使用した場合に密着性低下の原因となる。一方、(メタ)アクリレート化合物等のエチレン性不飽和化合物とチオール化合物を組み合わせたエン・チオール組成物は、硬化に伴う収縮が小さいことが知られている。 In general, a polyfunctional (meth) acrylate compound has a large shrinkage due to curing, and causes a decrease in adhesion when used as an adhesive. On the other hand, it is known that an ene / thiol composition obtained by combining an ethylenically unsaturated compound such as a (meth) acrylate compound and a thiol compound has a small shrinkage due to curing.

特許文献1には、A−BPEF、エチレン性不飽和化合物、およびチオール化合物から構成されるエン・チオール組成物が記載されている。実施例によると、硬化物の屈折率は高々1.58〜1.61の範囲である。
特許文献2には、MPSMA、ビニル系モノマー、およびポリチオール化合物から構成されるエン・チオール組成物が記載されている。実施例によると、硬化物の屈折率は最高で1.649である。しかしながら、MPSMAは黄着色しやすく、また固体であるため組成物への溶解量に限界があった。
また、特許文献3には、フルオレン環を有する樹脂成分と、MPSMA等のジフェニルスルフィド骨格を有する硫黄含有化合物とで構成される樹脂組成物が記載されており、屈折率1.724を有する樹脂が例示されている。しかしながら、該発明における樹脂組成物とは、実質的にはフルオレン環を有するポリエステルと硫黄含有化合物を混練した熱可塑性樹脂であって硬化性組成物ではなく、当然ながら光硬化性は付与できない。
Patent Document 1 describes an ene-thiol composition composed of A-BPEF, an ethylenically unsaturated compound, and a thiol compound. According to the examples, the refractive index of the cured product is at most in the range of 1.58 to 1.61.
Patent Document 2 describes an ene-thiol composition composed of MPSMA, a vinyl monomer, and a polythiol compound. According to the example, the refractive index of the cured product is 1.649 at the maximum. However, MPSMA is easily yellow-colored and has a limit in the amount of dissolution in the composition because it is solid.
Patent Document 3 describes a resin composition composed of a resin component having a fluorene ring and a sulfur-containing compound having a diphenyl sulfide skeleton such as MPSMA, and a resin having a refractive index of 1.724. Illustrated. However, the resin composition in the present invention is substantially a thermoplastic resin obtained by kneading a polyester having a fluorene ring and a sulfur-containing compound and is not a curable composition, and of course, photocurability cannot be imparted.

特開2010−254732号公報JP 2010-254732 A 特開平03−021638号公報JP 03-021638 A 特開2005−187661号公報JP 2005-187661 A

従って、本発明の目的は、更なる高屈折率化を目指し、且つ、低収縮性、光硬化性、無色透明性、作業に適した粘度といった光学用接着剤としての性能も兼ね備えた硬化性組成物を提供することにある。 Accordingly, an object of the present invention is to provide a curable composition that aims at further increasing the refractive index and also has performance as an optical adhesive such as low shrinkage, photocurability, colorless transparency, and viscosity suitable for work. To provide things.

本発明者らは、上記課題を解決するために鋭意検討した結果、フルオレン環を有するポリ(メタ)アクリレート化合物と、特定のチオアルキル構造を有するポリチオール化合物とを組み合わせたエン・チオール組成物が、更なる高屈折率化を可能にし、且つ光学用接着剤としての必要性能も兼ね備えることを見出した。さらに、ジ(チオフェニル)スルフィド構造やジ(チオフェニル)スルホン構造を有するエチレン性不飽和結合化合物を含有させることにより、物性バランスを維持しながら更なる高屈折率化を可能にすることを見出した。また、希釈性モノマーとして特定のエチレン性不飽和結合化合物を含有させることにより、物性バランスを維持しながら粘度を自由に調整できることを見出した。以上の知見をもとに本発明に至った。
なお、本明細書において、アクリレート化合物とメタクリレート化合物とを(メタ)アクリレート化合物と総称する。そのため、(メタ)アクリロイル基はアクリロイル基とメタクリロイル基の双方を包含する。
As a result of intensive studies to solve the above problems, the present inventors have further found an ene / thiol composition in which a poly (meth) acrylate compound having a fluorene ring and a polythiol compound having a specific thioalkyl structure are combined. It has been found that a higher refractive index can be achieved, and the necessary performance as an optical adhesive is also provided. Furthermore, it has been found that by containing an ethylenically unsaturated bond compound having a di (thiophenyl) sulfide structure or a di (thiophenyl) sulfone structure, it is possible to further increase the refractive index while maintaining the physical property balance. Moreover, it discovered that a viscosity could be adjusted freely, maintaining a physical property balance by containing a specific ethylenically unsaturated bond compound as a diluting monomer. The present invention has been achieved based on the above findings.
In the present specification, acrylate compounds and methacrylate compounds are collectively referred to as (meth) acrylate compounds. Therefore, the (meth) acryloyl group includes both an acryloyl group and a methacryloyl group.

本発明によれば、従来よりも高い屈折率を有し、且つ、低収縮性、光硬化性、無色透明性、作業に適した粘度といった光学用接着剤としての必要性能も兼ね備えた硬化性組成物を提供することができる。 According to the present invention, a curable composition having a higher refractive index than conventional ones and also having the necessary performance as an optical adhesive such as low shrinkage, photocurability, colorless transparency, and viscosity suitable for work. Things can be provided.

本発明の硬化性組成物は、フルオレン環を有するポリ(メタ)アクリレート化合物(A成分)、特定のチオアルキル構造を有するポリチオール化合物(B成分)、および光重合開始剤(C成分)を含有して構成される。さらに、ジ(チオフェニル)スルフィド構造、またはジ(チオフェニル)スルホン構造を有するエチレン性不飽和化合物(成分D)を含有することが好ましい。また、希釈性モノマーとしてA成分、D成分以外のエチレン性不飽和化合物(E成分)を含有することが好ましい。 The curable composition of this invention contains the poly (meth) acrylate compound (A component) which has a fluorene ring, the polythiol compound (B component) which has a specific thioalkyl structure, and a photoinitiator (C component). Composed. Furthermore, it is preferable to contain an ethylenically unsaturated compound (component D) having a di (thiophenyl) sulfide structure or a di (thiophenyl) sulfone structure. Moreover, it is preferable to contain ethylenically unsaturated compounds (E component) other than A component and D component as a diluting monomer.

フルオレン環を有するポリ(メタ)アクリレート化合物(A成分)とは、フルオレン環を有し、且つ1分子中に2個以上の(メタ)アクリロイル基を有する化合物である。フルオレン環は屈折率を高める効果がある。また、フルオレン環の嵩高い構造に起因して硬化に伴う収縮が小さい。特に、高屈折率化を追求した場合、下記一般式(2)

Figure 2012233113
(2)
(式中、mおよびnは、mとnの合計が0〜4を満たす整数を表し、Rは炭素数1〜5のアルキレン基を表し、Rは水素原子またはメチル基を表し、Rは水素原子またはメチル基を表す。)
で表わされる化合物が好ましい。前記の一般式(2)で表わされる化合物の例としては、9,9−ビス(4−(2−アクリロキシエトキシ)フェニル)フルオレン等が挙げられる。 The poly (meth) acrylate compound (component A) having a fluorene ring is a compound having a fluorene ring and having two or more (meth) acryloyl groups in one molecule. The fluorene ring has the effect of increasing the refractive index. Moreover, the shrinkage accompanying hardening is small due to the bulky structure of the fluorene ring. Especially when pursuing higher refractive index, the following general formula (2)
Figure 2012233113
(2)
(In the formula, m and n represent an integer in which the sum of m and n satisfies 0 to 4, R 1 represents an alkylene group having 1 to 5 carbon atoms, R 2 represents a hydrogen atom or a methyl group, R 3 represents a hydrogen atom or a methyl group.)
The compound represented by these is preferable. Examples of the compound represented by the general formula (2) include 9,9-bis (4- (2-acryloxyethoxy) phenyl) fluorene.

A成分は単独でも2種類以上を混合して使用しても構わない。A成分の含有量は特に限定されないが、硬化性組成物100重量部に対して、10〜90重量部の範囲が好ましく、30〜70重量部の範囲がより好ましい。 A component may be used individually or in mixture of 2 or more types. Although content of A component is not specifically limited, The range of 10-90 weight part is preferable with respect to 100 weight part of curable compositions, and the range of 30-70 weight part is more preferable.

特定のチオアルキル構造を有するポリチオール化合物(B成分)とは、下記一般式(1)

Figure 2012233113
(1)
(式中、pは0〜3の整数を表し、Rは単なる結合または炭素数1〜3のアルキレン基を表す。)
で表わされる化合物である。チオアルキル構造は原子屈折が高い硫黄原子を多く含有するため、屈折率を高める効果が大きい。また、A成分やD成分に含まれる芳香環は光や熱によって酸化されて黄変しやすいが、チオール基は酸化防止効果を有するため、無色透明性に優れた硬化物が得られる。また、A成分は常温で固体または高粘度の液体であるが、B成分による希釈効果で作業に適した粘度に調整される。また、チオール基のエチレン性不飽和結合との付加重合は硬化に伴う収縮が小さいため、接着剤として使用した場合に良好な密着性が得られる。前記の一般式(1)で表わされる化合物の例としては、2,5−ビス(ジメルカプトメチル)−1,4−ジチアン等が挙げられる。 The polythiol compound (component B) having a specific thioalkyl structure is represented by the following general formula (1)
Figure 2012233113
(1)
(In the formula, p represents an integer of 0 to 3, and R 4 represents a simple bond or an alkylene group having 1 to 3 carbon atoms.)
It is a compound represented by these. Since the thioalkyl structure contains many sulfur atoms having high atomic refraction, the effect of increasing the refractive index is great. Moreover, although the aromatic ring contained in A component and D component is easily oxidized and yellowed by light or heat, the thiol group has an antioxidant effect, so that a cured product having excellent colorless transparency can be obtained. The component A is a solid or high-viscosity liquid at room temperature, but is adjusted to a viscosity suitable for work by the dilution effect of the component B. Moreover, since the addition polymerization with the ethylenically unsaturated bond of a thiol group has small shrinkage | contraction accompanying hardening, when it uses as an adhesive agent, favorable adhesiveness is obtained. Examples of the compound represented by the general formula (1) include 2,5-bis (dimercaptomethyl) -1,4-dithiane.

B成分は単独でも2種類以上を混合して使用しても構わない。B成分は含有量が多いほど高屈折率化、低収縮性、無色透明性、および希釈効果に優れるが、チオール基はエチレン性不飽和結合基と1対1モルで付加反応するため、過剰のチオール基は未反応で残りやすく好ましくない。従って、B成分の含有量について、A成分、D成分、およびE成分に含まれるエチレン性不飽和結合基の総量に対して、B成分に含まれるチオール基の官能基当量比が0.2〜1.5の範囲であることが好ましく、0.5〜1.35の範囲であることがさらに好ましい。 The component B may be used alone or in combination of two or more. The higher the content of the B component, the higher the refractive index, the lower shrinkage, the colorless transparency, and the better the dilution effect. The thiol group is not preferable because it remains unreacted and remains. Therefore, regarding the content of the B component, the functional group equivalent ratio of the thiol group contained in the B component is 0.2 to the total amount of the ethylenically unsaturated bond groups contained in the A component, the D component, and the E component. It is preferably in the range of 1.5, more preferably in the range of 0.5 to 1.35.

光重合開始剤(C成分)とは、活性光線(紫外線、可視光など)の照射により、活性なラジカル種を生成させるものであれば特に限定されない。C成分の具体例としては、2,2−メトキシ−1,2−ジフェニルエタン−1−オン、1−ヒドロキシ−シクロヘキシルフェニルケトン、2−ヒドロキシ−2−メチル−1−フェニルプロパン−1−オン、2−メチル−1−[4−(メチルチオ)フェニル]−2−モルフォリノプロパン−1−オン、2−ベンジル−2−ジメチルアミノ−1−(4−モルフォリノフェニル)−ブタノン−1、ビス(2,4,6−トリメチルベンゾイル)−フェニルフォスフィンオキサイド、2,4,6−トリメチルベンゾイル−ジフェニル−フォスフィンオキサイド等が挙げられる。 The photopolymerization initiator (C component) is not particularly limited as long as it generates active radical species by irradiation with actinic rays (ultraviolet rays, visible light, etc.). Specific examples of component C include 2,2-methoxy-1,2-diphenylethane-1-one, 1-hydroxy-cyclohexyl phenyl ketone, 2-hydroxy-2-methyl-1-phenylpropan-1-one, 2-Methyl-1- [4- (methylthio) phenyl] -2-morpholinopropan-1-one, 2-benzyl-2-dimethylamino-1- (4-morpholinophenyl) -butanone-1, bis ( 2,4,6-trimethylbenzoyl) -phenylphosphine oxide, 2,4,6-trimethylbenzoyl-diphenyl-phosphine oxide, and the like.

C成分は単独でも2種類以上を混合して使用しても構わない。C成分の含有量は特に限定されないが、硬化性組成物100重量部に対して、0.1〜10重量部の範囲が好ましく、0.5〜5重量部の範囲がより好ましい。 The component C may be used alone or in combination of two or more. Although content of C component is not specifically limited, The range of 0.1-10 weight part is preferable with respect to 100 weight part of curable compositions, The range of 0.5-5 weight part is more preferable.

下記一般式(3)

Figure 2012233113
(3)
(式中、Xは硫黄原子またはスルホニル基を表し、Zは(メタ)アクリロイル基、ビニル基、またはアリル基を表わす。)
で表わされるエチレン性不飽和化合物(D成分)は、ジ(チオフェニル)スルフィド構造やジ(チオフェニル)スルホン構造に起因して屈折率を高める効果がある。前記の一般式(3)で表わされる化合物の例としては、4,4’−ビス(メタクリロイルチオ)ジフェニルスルフィド等が挙げられる。 The following general formula (3)
Figure 2012233113
(3)
(In the formula, X represents a sulfur atom or a sulfonyl group, and Z represents a (meth) acryloyl group, a vinyl group, or an allyl group.)
The ethylenically unsaturated compound (component D) represented by the formula is effective in increasing the refractive index due to the di (thiophenyl) sulfide structure and the di (thiophenyl) sulfone structure. Examples of the compound represented by the general formula (3) include 4,4′-bis (methacryloylthio) diphenyl sulfide.

D成分は単独でも2種類以上を混合して使用しても構わない。D成分は含有量が多いほど屈折率を高める効果が大きいが、一方で黄着色が大きくなり、また組成液に溶解しない場合がある。従って、D成分の含有量は、硬化性組成物100重量部に対して、50重量部以下の範囲が好ましく、35重量部以下の範囲がより好ましい。 The D component may be used alone or in combination of two or more. The greater the content of the component D, the greater the effect of increasing the refractive index. On the other hand, yellow coloring increases, and the component D may not dissolve in the composition liquid. Accordingly, the content of component D is preferably in the range of 50 parts by weight or less, more preferably in the range of 35 parts by weight or less, with respect to 100 parts by weight of the curable composition.

希釈性モノマーとして含有されるA成分、D成分以外のエチレン性不飽和化合物(E成分)とは、分子中に1個以上のエチレン性不飽和結合基を有する化合物であり、組成物の粘度を下げる効果があるものであれば限定されない。特には、屈折率を高める目的で芳香環や複素環を有する化合物が好ましい。E成分の好ましい具体例としては、イソシアヌル酸トリアリル、シアヌル酸トリアリル、フタル酸ジアリル、イソフタル酸ジアリル、テレフタル酸ジアリル、トリメリット酸トリアリル、ピロメリット酸テトラアリル、フェニル(メタ)アクリレート、2−フェノキシエチル(メタ)アクリレート、o−フェニルフェノール(メタ)アクリレート、2−(o−フェニルフェノキシ)エチル(メタ)アクリレート、ベンジル(メタ)アクリレート、2−(ベンジロキシ)エチル(メタ)アクリレート等が挙げられる。 An ethylenically unsaturated compound (component E) other than component A and component D contained as a dilutable monomer is a compound having one or more ethylenically unsaturated bond groups in the molecule, and the viscosity of the composition is There is no limitation as long as it has an effect of lowering. In particular, a compound having an aromatic ring or a heterocyclic ring is preferable for the purpose of increasing the refractive index. Preferable specific examples of the E component include triallyl isocyanurate, triallyl cyanurate, diallyl phthalate, diallyl isophthalate, diallyl terephthalate, triallyl trimellitic acid, tetraallyl pyromellitic acid, phenyl (meth) acrylate, 2-phenoxyethyl ( Examples include meth) acrylate, o-phenylphenol (meth) acrylate, 2- (o-phenylphenoxy) ethyl (meth) acrylate, benzyl (meth) acrylate, and 2- (benzyloxy) ethyl (meth) acrylate.

E成分は単独でも2種類以上を混合して使用しても構わない。E成分は含有量が多いほど希薄効果が高いが、一方で屈折率が低下する。従って、E成分の含有量は、硬化性組成物100重量部に対して、40重量部以下の範囲が好ましく、25重量部以下の範囲がより好ましい。 The E component may be used alone or in combination of two or more. The greater the content of component E, the higher the dilution effect, but the lower the refractive index. Therefore, the content of the component E is preferably in the range of 40 parts by weight or less, more preferably in the range of 25 parts by weight or less with respect to 100 parts by weight of the curable composition.

本発明の硬化性組成物には必要に応じて、重合禁止剤、酸化防止剤、光安定剤(HALS)、紫外線吸収剤、シランカップリング剤、離型剤、顔料、染料等を添加することが可能である。 If necessary, a polymerization inhibitor, an antioxidant, a light stabilizer (HALS), an ultraviolet absorber, a silane coupling agent, a release agent, a pigment, a dye, and the like may be added to the curable composition of the present invention. Is possible.

本発明の硬化性組成物は、常法に準じて、常温または加温下で、各成分を均一に混合することにより得られる。混合後の組成物は必要に応じて、ろ過や脱泡などを行っても構わない。 The curable composition of this invention is obtained by mixing each component uniformly according to a conventional method at normal temperature or under heating. The composition after mixing may be filtered or defoamed as necessary.

光学用接着剤の粘度に関して、粘度が低すぎると、接着剤が垂れたり流れたり、張り合わせの際に基板がずれたりして好ましくない。また、粘度が高すぎると、接着剤の吐出や塗布が困難になったり、張り合わせの際に気泡が噛んだりして好ましくない。本発明で言う作業性に適した粘度とは、塗布方法や張り合わせ方法といった接着剤の使用形態にも依るので一概には規定できないが、好ましくは1,000〜30,000mPa・sの範囲であり、より好ましくは1,000〜10,000mPa・sの範囲である。 Regarding the viscosity of the optical adhesive, if the viscosity is too low, the adhesive may sag or flow, or the substrate may be displaced during pasting. On the other hand, if the viscosity is too high, it is not preferable because it becomes difficult to discharge or apply the adhesive, or bubbles are bitten during the bonding. The viscosity suitable for workability in the present invention depends on the use form of the adhesive such as the coating method and the laminating method, and cannot be defined unconditionally, but is preferably in the range of 1,000 to 30,000 mPa · s. More preferably, it is in the range of 1,000 to 10,000 mPa · s.

以下、実施例により本発明を具体的に説明するが、本発明はこれらに限定されるものではない。なお、実施例中における硬化収縮率は、下記の計算式に従い、硬化前後における屈折率から計算した。
X=(1−d1/d2)×100[%]
R=(n−1)/(n+2)×M/d
硬化前後でR/Mは一定なので、上の2式より、
X=[1−{(n1−1)/(n1+2)}/{(n2−1)/(n2+2)}]×100[%]
(式中、Xは硬化収縮率、dは比重、d1は硬化前の比重、d2は硬化後の比重、Rは分子屈折、nは屈折率、n1は硬化前の屈折率、n2は硬化後の屈折率、Mは分子量を表す。)
EXAMPLES Hereinafter, the present invention will be specifically described with reference to examples, but the present invention is not limited thereto. In addition, the cure shrinkage rate in an Example was computed from the refractive index before and behind hardening according to the following formula.
X = (1−d1 / d2) × 100 [%]
R = (n 2 −1) / (n 2 +2) × M / d
Since R / M is constant before and after curing,
X = [1-{(n1 2 −1) / (n1 2 +2)} / {(n2 2 −1) / (n2 2 +2)}] × 100 [%]
(Where X is the curing shrinkage ratio, d is the specific gravity, d1 is the specific gravity before curing, d2 is the specific gravity after curing, R is the molecular refraction, n is the refractive index, n1 is the refractive index before curing, and n2 is the after curing. The refractive index of M and M represents the molecular weight.)

また、硬化性組成物の粘度は、コーン/プレート型粘度計DV−II+(ブルックフィールド社製)を用いて、温度25℃にて測定した。硬化性組成物および硬化物の屈折率は、アッベ屈折計NAR−3T(アタゴ社製)を用いて測定した。硬化物の透過率は、分光光度計U−3500(日立ハイテク社製)を用いて、硬化物の厚み0.25mm、波長400nmにて測定した。 The viscosity of the curable composition was measured at a temperature of 25 ° C. using a cone / plate viscometer DV-II + (manufactured by Brookfield). The refractive indexes of the curable composition and the cured product were measured using an Abbe refractometer NAR-3T (manufactured by Atago Co., Ltd.). The transmittance of the cured product was measured using a spectrophotometer U-3500 (manufactured by Hitachi High-Tech) at a thickness of 0.25 mm and a wavelength of 400 nm.

実施例1
300mlフラスコに、9,9−ビス(4−(2−アクリロキシエトキシ)フェニル)フルオレン66g(A成分)、1,5−ジメルカプト−3−チアペンタン34g(B成分)、および1−ヒドロキシ−シクロヘキシルフェニルケトン3g(C成分)をとり、60℃にて1時間撹拌して硬化性組成物を作製した。
硬化性組成物を離型処理された2枚のガラス板で挟み、メタルハライドランプ(120W/cm)の光を30cmの距離から3分間照射した。以上の手順で厚み0.25mmの硬化膜を作製した。
硬化性組成物および硬化膜の物性は表1に示す通りであった。
Example 1
In a 300 ml flask, 66 g of 9,9-bis (4- (2-acryloxyethoxy) phenyl) fluorene (component A), 34 g of 1,5-dimercapto-3-thiapentane (component B), and 1-hydroxy-cyclohexylphenyl 3 g of ketone (C component) was taken and stirred at 60 ° C. for 1 hour to prepare a curable composition.
The curable composition was sandwiched between two release-treated glass plates and irradiated with light from a metal halide lamp (120 W / cm) for 3 minutes from a distance of 30 cm. A cured film having a thickness of 0.25 mm was produced by the above procedure.
The physical properties of the curable composition and the cured film were as shown in Table 1.

実施例2〜8
A成分、B成分、D成分、およびE成分の種類および仕込み量を表1に示す内容に変える以外は実施例1と同様にして硬化性組成物および硬化物の作製を行った。硬化性組成物および硬化膜の物性は表1に示す通りであった。
Examples 2-8
A curable composition and a cured product were prepared in the same manner as in Example 1 except that the types and amounts of components A, B, D, and E were changed to the contents shown in Table 1. The physical properties of the curable composition and the cured film were as shown in Table 1.

比較例1〜10
A成分、B成分、D成分、およびE成分の種類および仕込み量を表2に示す内容に変える以外は実施例1と同様にして硬化性組成物および硬化物の作製を行った。硬化性組成物および硬化膜の物性は表2に示す通りであった。なお、実施例と比較して物性が劣る値には下線を引いた。
Comparative Examples 1-10
A curable composition and a cured product were prepared in the same manner as in Example 1 except that the types and amounts of components A, B, D, and E were changed to those shown in Table 2. The physical properties of the curable composition and the cured film were as shown in Table 2. In addition, the value in which a physical property is inferior compared with an Example was underlined.

Figure 2012233113
Figure 2012233113

Figure 2012233113
Figure 2012233113

Figure 2012233113
補足説明
比較例1:25℃で固体状態だったため、測定できなかった。
Figure 2012233113
Supplementary explanation Comparative example 1: Since it was a solid state at 25 degreeC, it was not able to measure.

Figure 2012233113
補足説明
比較例6:MPSMA(d−1)が溶けきらなかったため、測定できなかった。
比較例7:UV光を照射しても硬化しなかったため、測定できなかった。
Figure 2012233113
Supplementary explanation Comparative example 6: MPSMA (d-1) could not be measured because it was not completely dissolved.
Comparative Example 7: Measurement could not be performed because the resin was not cured even when irradiated with UV light.

表中略語の説明
(a−1)9,9−ビス(4−(2−アクリロキシエトキシ)フェニル)フルオレン
(a−2)2,2−ビス(4−(アクリロキシジエトキシ)フェニル)プロパン
(b−1)2,5−ジメルカプトメチル−1,4−ジチアン
(b−2)ペンタエリスリトールテトラキス(3−メルカプトブチレート)
(b−3)1,5−ジメルカプト−3−チアペンタン
(d−1)4,4’−ビス(メタクリロイルチオ)ジフェニルスルフィド
(e−1)イソシアヌル酸トリアリル
(e−2)ベンジルアクリレート
(e−3)2−(o−フェニルフェノキシ)エチルアクリレート
(e−4)フタル酸ジアリル
(e−5)2−フェノキシエチルアクリレート
(e−6)ジビニルベンゼン
Explanation of Abbreviations in Table (a-1) 9,9-Bis (4- (2-acryloxyethoxy) phenyl) fluorene (a-2) 2,2-bis (4- (acryloxydiethoxy) phenyl) propane (B-1) 2,5-dimercaptomethyl-1,4-dithiane (b-2) pentaerythritol tetrakis (3-mercaptobutyrate)
(B-3) 1,5-dimercapto-3-thiapentane (d-1) 4,4′-bis (methacryloylthio) diphenyl sulfide (e-1) isaryluric acid triallyl (e-2) benzyl acrylate (e-3 ) 2- (o-phenylphenoxy) ethyl acrylate (e-4) diallyl phthalate (e-5) 2-phenoxyethyl acrylate (e-6) divinylbenzene

Claims (9)

フルオレン環を有するポリ(メタ)アクリレート化合物(A成分)、下記一般式(1)
Figure 2012233113
(1)
(式中、pは0〜3の整数を表し、Rは単なる結合または炭素数1〜3のアルキレン基を表す。)
で表わされるポリチオール化合物(B成分)、および光重合開始剤(C成分)を含有する硬化性組成物。
Poly (meth) acrylate compound having a fluorene ring (component A), the following general formula (1)
Figure 2012233113
(1)
(In the formula, p represents an integer of 0 to 3, and R 4 represents a simple bond or an alkylene group having 1 to 3 carbon atoms.)
The curable composition containing the polythiol compound (B component) represented by these, and a photoinitiator (C component).
A成分が下記一般式(2)
Figure 2012233113
(2)
(式中、mおよびnは、mとnの合計が0〜4を満たす整数を表し、Rは炭素数1〜5のアルキレン基を表し、Rは水素原子またはメチル基を表し、Rは水素原子またはメチル基を表す。)
で表わされる化合物である請求項1に記載の硬化性組成物。
A component is the following general formula (2)
Figure 2012233113
(2)
(In the formula, m and n represent an integer in which the sum of m and n satisfies 0 to 4, R 1 represents an alkylene group having 1 to 5 carbon atoms, R 2 represents a hydrogen atom or a methyl group, R 3 represents a hydrogen atom or a methyl group.)
The curable composition of Claim 1 which is a compound represented by these.
一般式(2)で表わされる化合物が9,9−ビス(4−(2−アクリロキシエトキシ)フェニル)フルオレンである請求項2に記載の硬化性組成物 The curable composition according to claim 2, wherein the compound represented by the general formula (2) is 9,9-bis (4- (2-acryloxyethoxy) phenyl) fluorene. 一般式(1)で表わされる化合物が2,5−ビス(ジメルカプトメチル)−1,4−ジチアンである請求項1から3のいずれかに記載の硬化性組成物。 The curable composition according to any one of claims 1 to 3, wherein the compound represented by the general formula (1) is 2,5-bis (dimercaptomethyl) -1,4-dithiane. さらに下記一般式(3)
Figure 2012233113
(3)
(式中、Xは硫黄原子またはスルホニル基を表し、Zは(メタ)アクリロイル基、ビニル基、またはアリル基を表わす。)
で表わされるエチレン性不飽和化合物(D成分)を含有する請求項1から4のいずれかに記載の硬化性組成物。
Furthermore, the following general formula (3)
Figure 2012233113
(3)
(In the formula, X represents a sulfur atom or a sulfonyl group, and Z represents a (meth) acryloyl group, a vinyl group, or an allyl group.)
The curable composition in any one of Claim 1 to 4 containing the ethylenically unsaturated compound (D component) represented by these.
一般式(3)で表わされる化合物が4,4’−ビス(メタクリロイルチオ)ジフェニルスルフィドである請求項5に記載の硬化性組成物。 The curable composition according to claim 5, wherein the compound represented by the general formula (3) is 4,4'-bis (methacryloylthio) diphenyl sulfide. さらに希釈性モノマーとしてA成分、D成分以外のエチレン性不飽和化合物(E成分)を含有する請求項1から6のいずれかに記載の硬化性組成物。 Furthermore, the curable composition in any one of Claim 1 to 6 which contains an ethylenically unsaturated compound (E component) other than A component and D component as a diluting monomer. E成分が、イソシアヌル酸トリアリル、シアヌル酸トリアリル、フタル酸ジアリル、イソフタル酸ジアリル、テレフタル酸ジアリル、トリメリット酸トリアリル、ピロメリット酸テトラアリル、フェニル(メタ)アクリレート、2−フェノキシエチル(メタ)アクリレート、o−フェニルフェノール(メタ)アクリレート、2−(o−フェニルフェノキシ)エチル(メタ)アクリレート、ベンジル(メタ)アクリレートおよび2−(ベンジロキシ)エチル(メタ)アクリレートから成る群から選択される一種以上の化合物である請求7に記載の硬化性組成物。 E component is triallyl isocyanurate, triallyl cyanurate, diallyl phthalate, diallyl isophthalate, diallyl terephthalate, triallyl trimellitic acid, tetraallyl pyromellitic acid, phenyl (meth) acrylate, 2-phenoxyethyl (meth) acrylate, o One or more compounds selected from the group consisting of phenylphenol (meth) acrylate, 2- (o-phenylphenoxy) ethyl (meth) acrylate, benzyl (meth) acrylate and 2- (benzyloxy) ethyl (meth) acrylate The curable composition according to claim 7. 請求項1から8のいずれかに記載の硬化性組成物からなる光学用接着剤。 An optical adhesive comprising the curable composition according to claim 1.
JP2011103642A 2011-04-28 2011-05-06 Curable composition and optical adhesive Active JP5754233B2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2011103642A JP5754233B2 (en) 2011-05-06 2011-05-06 Curable composition and optical adhesive
CN201280020113.7A CN103562271B (en) 2011-04-28 2012-04-24 Solidification compound and optics caking agent
PCT/JP2012/060903 WO2012147712A1 (en) 2011-04-28 2012-04-24 Curable composition and adhesive for optical applications
TW101114703A TWI529488B (en) 2011-04-28 2012-04-25 A hardening composition and an optical follower

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011103642A JP5754233B2 (en) 2011-05-06 2011-05-06 Curable composition and optical adhesive

Publications (2)

Publication Number Publication Date
JP2012233113A true JP2012233113A (en) 2012-11-29
JP5754233B2 JP5754233B2 (en) 2015-07-29

Family

ID=47433756

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011103642A Active JP5754233B2 (en) 2011-04-28 2011-05-06 Curable composition and optical adhesive

Country Status (1)

Country Link
JP (1) JP5754233B2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014201682A (en) * 2013-04-05 2014-10-27 日立化成株式会社 Adhesive composition, adhesive for circuit connection, and connection structure for circuit member
JP2017057401A (en) * 2013-09-05 2017-03-23 株式会社ダイセル Adhesive and sealing material
JPWO2016031406A1 (en) * 2014-08-27 2017-06-29 富士フイルム株式会社 Compound, composition, film, optical instrument
WO2018062196A1 (en) * 2016-09-28 2018-04-05 旭硝子株式会社 Curable composition and cured product
WO2023238828A1 (en) * 2022-06-09 2023-12-14 株式会社ダイセル Curable composition

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0321638A (en) * 1989-06-20 1991-01-30 Showa Denko Kk Curable composition
JP2005139401A (en) * 2003-11-10 2005-06-02 Sekisui Chem Co Ltd Photocurable adhesive agent for polarization plate and liquid crystal display panel
JP2009074037A (en) * 2007-08-24 2009-04-09 Mitsubishi Gas Chem Co Inc Resin composition for optical material
JP2010254732A (en) * 2009-04-21 2010-11-11 Osaka Gas Chem Kk Curable composition and cured product of the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0321638A (en) * 1989-06-20 1991-01-30 Showa Denko Kk Curable composition
JP2005139401A (en) * 2003-11-10 2005-06-02 Sekisui Chem Co Ltd Photocurable adhesive agent for polarization plate and liquid crystal display panel
JP2009074037A (en) * 2007-08-24 2009-04-09 Mitsubishi Gas Chem Co Inc Resin composition for optical material
JP2010254732A (en) * 2009-04-21 2010-11-11 Osaka Gas Chem Kk Curable composition and cured product of the same

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014201682A (en) * 2013-04-05 2014-10-27 日立化成株式会社 Adhesive composition, adhesive for circuit connection, and connection structure for circuit member
JP2017057401A (en) * 2013-09-05 2017-03-23 株式会社ダイセル Adhesive and sealing material
JPWO2016031406A1 (en) * 2014-08-27 2017-06-29 富士フイルム株式会社 Compound, composition, film, optical instrument
WO2018062196A1 (en) * 2016-09-28 2018-04-05 旭硝子株式会社 Curable composition and cured product
JPWO2018062196A1 (en) * 2016-09-28 2019-07-11 Agc株式会社 Curable composition and cured product
US10611869B2 (en) 2016-09-28 2020-04-07 AGC Inc. Curable composition and cured product
WO2023238828A1 (en) * 2022-06-09 2023-12-14 株式会社ダイセル Curable composition

Also Published As

Publication number Publication date
JP5754233B2 (en) 2015-07-29

Similar Documents

Publication Publication Date Title
JP5810611B2 (en) Curable composition and optical adhesive
WO2012147712A1 (en) Curable composition and adhesive for optical applications
CN106414525B (en) Photocurable resin composition
JP6816719B2 (en) Curable composition and optical adhesive using it
JP5754233B2 (en) Curable composition and optical adhesive
JP6063228B2 (en) Photocurable resin composition
JP5779039B2 (en) Hard coat resin composition and cured product thereof
TWI521035B (en) A hardening composition and an optical follower
WO2013183532A1 (en) Resin composition for coating materials
JP5991315B2 (en) Curable composition and optical adhesive
TW201518384A (en) Coating material resin composition
JP2003238904A (en) Photocuring adhesive composition for optical use
JP5849432B2 (en) Curable composition and optical adhesive
JP5834475B2 (en) Curable composition and optical adhesive
WO2012147711A1 (en) Curable composition and adhesive for optical applications
JP5810610B2 (en) Curable composition and optical adhesive
JP5742443B2 (en) Curable composition and optical adhesive
WO2020188993A1 (en) Curable resin composition and cured product thereof
JP6507683B2 (en) Resin composition and optical member
JP2023039162A (en) Curable resin composition and cured material
JP6020030B2 (en) Heat and weather resistant resin composition
WO2022181725A1 (en) Curable resin composition and cemented lens
JP2018016744A (en) Photopolymerizable composition and cured product thereof, and microlens forming agent and microlens comprising the same

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140318

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150120

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150317

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150407

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150408

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150428

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150511

R151 Written notification of patent or utility model registration

Ref document number: 5754233

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151